Schroder Investment Management Group Ascendis Pharma A/S Transaction History

Schroder Investment Management Group

$101 Billion
Q4 2024

A detailed history of Schroder Investment Management Group transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Schroder Investment Management Group holds 92,728 shares of ASND stock, worth $14.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

92,728

Previous 80,989 14.49%

Holding current value

$14.5 Million

Previous $12.1 Million 5.55%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$122.0 - $146.6 $1.43 Million - $1.72 Million	11,739 Added 14.49%	92,728 $12.8 Million
Q3 2024 Nov 13, 2024	BUY	$113.0 - $153.43 $4.08 Million - $5.53 Million	36,071 Added 80.3%	80,989 $12.1 Million
Q2 2024 Aug 12, 2024	BUY	$121.07 - $153.67 $5.44 Million - $6.9 Million	44,918 New	44,918 $6.13 Million
Q4 2022 Feb 10, 2023	BUY	$99.42 - $131.97 $208,185 - $276,345	2,094 Added 3.6%	60,221 $7.35 Million
Q3 2022 Nov 10, 2022	BUY	$84.03 - $110.23 $584,260 - $766,429	6,953 Added 13.59%	58,127 $6 Million
Q2 2022 Aug 11, 2022	BUY	$78.08 - $117.61 $67,851 - $102,203	869 Added 1.73%	51,174 $4.76 Million
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $1.37 Million - $1.81 Million	13,362 Added 36.17%	50,305 $5.84 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $215,434 - $287,573	1,695 Added 4.81%	36,943 $4.97 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $1.4 Million - $2.21 Million	12,468 Added 54.73%	35,248 $5.62 Million
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $209,551 - $250,334	1,723 Added 8.18%	22,780 $3 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $263,581 - $365,726	2,110 Added 11.14%	21,057 $2.71 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $66,679 - $80,597	-441 Reduced 2.27%	18,947 $3.16 Million
Q3 2020 Nov 13, 2020	BUY	$134.29 - $154.32 $222,787 - $256,016	1,659 Added 9.36%	19,388 $3.08 Million
Q2 2020 Aug 13, 2020	BUY	$110.87 - $156.01 $353,786 - $497,827	3,191 Added 21.95%	17,729 $2.62 Million
Q1 2020 May 15, 2020	BUY	$97.01 - $145.11 $4,462 - $6,675	46 Added 0.32%	14,538 $1.72 Million
Q3 2019 Nov 12, 2019	BUY	$95.8 - $118.9 $1.39 Million - $1.72 Million	14,492 New	14,492 $1.39 Million

Others Institutions Holding ASND

# of Institutions

236

Shares Held

60.2M

Call Options Held

80.3K

Put Options Held

216K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.74B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Ascendis Pharma A/S Transaction History